These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1049 related items for PubMed ID: 23985562

  • 1. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.
    Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society.
    Menopause; 2007 Sep; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [Abstract] [Full Text] [Related]

  • 4. Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction.
    Santoro N, Worsley R, Miller KK, Parish SJ, Davis SR.
    J Sex Med; 2016 Mar; 13(3):305-16. PubMed ID: 26944462
    [Abstract] [Full Text] [Related]

  • 5. Ospemifene for the treatment of vulvovaginal atrophy and dyspareunia in postmenopausal women.
    McLendon AN, Clinard VB, Woodis CB.
    Pharmacotherapy; 2014 Oct; 34(10):1050-60. PubMed ID: 25052122
    [Abstract] [Full Text] [Related]

  • 6. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
    Tan O, Bradshaw K, Carr BR.
    Menopause; 2012 Jan; 19(1):109-17. PubMed ID: 22011753
    [Abstract] [Full Text] [Related]

  • 11. What should guide our patient management of vulvovaginal atrophy?
    Shapiro M.
    Climacteric; 2019 Feb; 22(1):38-43. PubMed ID: 30452294
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The 2017 hormone therapy position statement of The North American Menopause Society.
    The NAMS 2017 Hormone Therapy Position Statement Advisory Panel.
    Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Hocké C, Diaz M, Bernard V, Frantz S, Lambert M, Mathieu C, Grellety-Cherbero M.
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):394-413. PubMed ID: 33757926
    [Abstract] [Full Text] [Related]

  • 18. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF, Kimble TD, Lin FDY, Battucci S, Sniukiene V, Liu JH.
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.